A complex systems perspective on psychedelic brain action
This commentary (2023) discusses the potential transdiagnostic efficacy of psychedelic-assisted therapy and its impact on brain function. It proposes that psychedelics induce a mode of brain function that is more dynamically flexible, diverse, integrated, and tuned for information sharing, which is consistent with greater criticality, and suggests that a complexity science perspective may help in understanding the inconsistencies in previous findings and guide towards compelling mechanistic models.
Authors
- Fernando Rosas
- Robin Carhart-Harris
- Manesh Girn
Published
Abstract
Recent findings suggesting the potential transdiagnostic efficacy of psychedelic-assisted therapy have fostered the need to deepen our understanding of psychedelic brain action. Functional neuroimaging investigations have found that psychedelics reduce the functional segregation of large-scale brain networks. However, beyond this general trend, findings have been largely inconsistent. We argue here that a perspective based on complexity science that foregrounds the distributed, interactional, and dynamic nature of brain function may render these inconsistencies intelligible. We propose that psychedelics induce a mode of brain function that is more dynamically flexible, diverse, integrated, and tuned for information sharing, consistent with greater criticality. This ‘meta’ perspective has the potential to unify past findings and guide intuitions toward compelling mechanistic models.
Research Summary of 'A complex systems perspective on psychedelic brain action'
Introduction
Earlier neuroimaging work on serotonergic psychedelics (for example LSD, psilocybin, and DMT) has repeatedly reported a broad tendency toward reduced functional differentiation of large-scale brain networks — described here as increased global integration — yet attempts to identify consistent region- or network-specific correlates of the acute psychedelic state have produced heterogeneous and often contradictory results. Girn and colleagues note that conventional resting‑state fMRI analyses, which focus on time-averaged, location-specific functional connectivity (FC) within or between predefined networks, have yielded little spatial convergence across drugs, laboratories, or analytic pipelines. This inconsistency is further complicated by observations that some network changes attributed to psychedelics are not unique to them and by methodological factors such as differing parcellation strategies and individual variability in brain topography. To address this gap, the study proposes a ‘‘meta’’ perspective grounded in complexity science. Rather than seeking a canonical spatial fingerprint, the investigators aim to reinterpret existing findings through a whole-brain, dynamical-systems lens: they argue that psychedelics shift the brain into a distinct dynamical mode that is more flexible, diverse, integrated, and tuned for information sharing — a regime closer to criticality. The paper therefore reviews region- and network-focused fMRI results, presents didactic material on complexity approaches, surveys empirical studies that have applied such approaches to psychedelic datasets, and advances a theoretical framework that foregrounds spatiotemporal trajectories and individual variability as central to understanding psychedelic brain action.
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Study Details
- Study Typemeta
- Journal
- Topic
- Authors
- APA Citation
Girn, M., Rosas, F. E., Daws, R. E., Gallen, C. L., Gazzaley, A., & Carhart-Harris, R. L. (2023). A complex systems perspective on psychedelic brain action. Trends in Cognitive Sciences, 27(5), 433-445. https://doi.org/10.1016/j.tics.2023.01.003
References (50)
Papers cited by this study that are also in Blossom
Vollenweider, F. X., Preller, K. H. · Nature Reviews Neuroscience (2020)
Johnson, M. W., Hendricks, P. S., Barrett, F. S. et al. · Pharmacology and Therapeutics (2019)
Doss, M. K., Madden, M. B., Gaddis, A. et al. · Brain (2021)
Carhart-Harris, R. L., Friston, K. J. · Pharmacological Reviews (2019)
McCulloch, D. E-W., Knudsen, G. M., Barrett, F. S. et al. · Neuroscience and Biobehavioral Reviews (2022)
Daws, R. E., Timmermann, C., Giribaldi, B. et al. · Nature Medicine (2022)
Müller, F., Dolder, P. C., Schmidt, A. et al. · NeuroImage (2018)
Roseman, L., Leech, R., Feilding, A. et al. · Frontiers in Human Neuroscience (2014)
Carhart-Harris, R. L., Muthukumaraswamy, S., Roseman, L. et al. · PNAS (2016)
Mason, N. L., Kuypers, K. P. C., Reckweg, J. et al. · Neuropsychopharmacology (2020)
Show all 50 referencesShow fewer
Madsen, M. K., Stenbaek, D. S., Arvidsson, A. et al. · European Neuropsychopharmacology (2021)
Preller, K. H., Burt, J. B., Adkinson, B. et al. · eLife (2018)
Tagliazucchi, E., Roseman, L., Kaelen, M. et al. · Current Biology (2016)
Girn, M., Roseman, L., Bernhardt, B. et al. · NeuroImage (2022)
Holze, F., Dolder, P. C., Ley, L. et al. · Neuropsychopharmacology (2020)
Doss, M. K., May, D. G., Johnson, M. W. et al. · Scientific Reports (2020)
Hipólito, I., Mago, J., Rosas, F. E. et al. · Psyarxiv (2022)
Hartogsohn, I. · Journal of Psychopharmacology (2016)
Carhart-Harris, R. L., Erritzoe, D., Williams, T. et al. · PNAS (2012)
Palhano-Fontes, F., Andrade, K. C., Tófoli, L.F. et al. · PLOS ONE (2015)
Avram, M., Rogg, H., Korda, A. et al. · Frontiers in Psychiatry (2021)
Lenz, C., Dolder, P. C., Lang, U. E. et al. · Acta Psychiatrica Scandinavica (2017)
Avram, M., Müller, F., Rogg, H. et al. · Biological Psychiatry (2022)
Gaddis, A., Lidstone, D. E., Nebel, M. B. et al. · Biorxiv (2022)
Lord, L. D., Expert, P., Atasoy, S. et al. · NeuroImage (2019)
Jobst, B. M., Atasoy, S., Ponce-Alvarez, A. et al. · NeuroImage (2021)
Carhart-Harris, R. L. · Neuropharmacology (2018)
Carhart-Harris, R. L., Leech, R., Shanahan, M. et al. · Frontiers in Human Neuroscience (2014)
Varley, T. F., Carhart-Harris, R., Roseman, L. et al. · NeuroImage (2020)
Luppi, A. I., Carhart-Harris, R. L., Roseman, L. et al. · NeuroImage (2021)
Lebedev, A. V., Kaelen, M., L€ Ovd En, M. et al. · Human Brain Mapping (2016)
Timmermann, C., Roseman, L., Schartner, M. et al. · Scientific Reports (2019)
Schartner, M., Carhart-Harris, R. L., Barrett, A. B. et al. · Scientific Reports (2017)
Viol, A., Palhano-Fontes, F., Onias, H. et al. · Scientific Reports (2017)
Alonso, J. N., Romero, S., Mañanas, M. A. et al. · International Journal of Neuropsychopharmacology (2015)
Preller, K. H., Vollenweider, F. X. · Behavioral Neurobiology of Psychedelic Drugs (2016)
Singleton, S. P., Luppi, A. I., Carhart-Harris, R. L. et al. · Nature Communications (2022)
Davis, A. K., Streeter Barrett, F., Griffiths, R. R. et al. · Journal of Psychopharmacology (2021)
Breeksema, J. J., Niemeijer, A. R., Krediet, E. et al. · CNS Drugs (2020)
Kraehenmann, R. · Current Neuropharmacology (2017)
Sumiyoshi, T., Kraehenmann, R., Pokorny, D. et al. · Frontiers in Pharmacology (2017)
Girn, M., Mills, C., Roseman, L. et al. · NeuroImage (2020)
Carhart-Harris, R. L., Nutt, D. J. · Journal of Psychopharmacology (2017)
Barrett, F. S., Griffiths, R. R. · Current Topics in Behavioral Neurosciences (2017)
Nour, M. R., Evans, J., Nutt, D. J. et al. · Frontiers in Human Neuroscience (2016)
Wießner, I., Falchi, M., Maia, L. O. et al. · Journal of Psychopharmacology (2022)
Family, N., Vinson, D., Vigliocco, G. et al. · Language Cognition and Neuroscience (2016)
Kwan, A. C., Olson, D. E., Preller, K. H. et al. · Nature Medicine (2022)
Timmermann, C., Vollenweider, F. X. · Trends in Cognitive Sciences (2023)
Timmermann, C., Roseman, L., Haridas, S. et al. · PNAS (2023)
Cited By (14)
Papers in Blossom that reference this study
Girn, M., Doss, M. K., Roseman, L. et al. · Nature Medicine (2026)
Mallaroni, P., Singleton, P., Mason, N. L. et al. · Molecular Psychiatry (2026)
Blackburne, G., Mcalpine, R. G., Fabus, M. et al. · Cell Reports (2025)
Singleton, S. P., Timmermann, C., Luppi, A. I. et al. · Communications Biology (2025)
Coleman, J. A., Shinozuka, K., Tromm, R. et al. · Human Brain Mapping (2025)
Piccinini, J. I., Perl, Y. S., Pallavicini, C. et al. · Communications Biology (2025)
Nicol, G. E. · Nature (2024)
Lewis, E. C., Jaeger, A., Girn, M. et al. · Journal of Psychopharmacology (2024)
Juliani, A., Chelu, V., Graesser, L. et al. · Biorxiv (2024)
Peill, J. M., Marguilho, M., Erritzoe, D. et al. · Journal of Psychopharmacology (2024)
Show all 14 papersShow fewer
Tap, S. C. · Addiction Biology (2024)
Erritzoe, D., Timmermann, C., Godfrey, K. et al. · Nature Mental Health (2024)
Rosas, F. E., Mediano, P. A. M., Timmermann, C. et al. · Biorxiv (2023)
Lawrence, D. W., Timmermann, C. · Journal of Psychoactive Drugs (2023)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.